Rhoda Feng is a freelance writer who splits her time between New York and Washington, DC. Her work has appeared in 4Columns, the Baffler, BOMB, the White Review, the Hedgehog Review, Public Books, Paris Review Daily, the Atlantic, the Guardian, the New Republic, the Los Angeles Review of Books, Salon, and elsewhere.
New drugs are developed with vast amounts of taxpayer money. But instead of universal access to these publicly funded scientific achievements, we get prohibitively expensive medicine and sky-high profits for pharmaceutical companies.